The Effect of Tongguan Capsule for MicroRNA Profiles in Coronary Heart Disease Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT02850627

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02850627
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02850627. Randomized; double masking; primary purpose prevention. Start 2016-07 (registry gives no type); primary completion 2017-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effect of Tongguan Capsule for MicroRNA Profiles in Coronary Heart Disease Patients
Condition
Coronary Heart Disease
Condition
Acute Myocardial Infarction
Intervention (Drug)
Tongguan capsule
Intervention (Drug)
placebo capsule
Lead sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine (class: other)

Record details

Record id
cardio:ct-nct02850627
Content hash
7c13f3baa23808ad5d362eb3755b7e06580b5e5c771b10bf557bf9a4bf4aee85